首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Decreased biliary excretion of piperacillin after percutaneous relief of extrahepatic obstructive jaundice.
【2h】

Decreased biliary excretion of piperacillin after percutaneous relief of extrahepatic obstructive jaundice.

机译:经皮缓解肝外阻塞性黄疸后哌拉西林的胆汁排泄减少。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The biliary excretion of piperacillin has been assessed in 11 patients with obstructive jaundice due to hilar cholangiocarcinoma. After a 1-g intravenous dose administered 30 min before preliminary percutaneous transhepatic cholangiography, no drug was detected in the bile of seven patients; in four others, drug concentrations were far below the corresponding level in serum. After a period of external biliary drainage of up to 28 days, levels of antibiotic in bile after intravenous administration were only minimally increased. The results suggest that although the impairment of hepatic function may be improved by external biliary decompression when assessed by a fall in plasma bilirubin, the biliary elimination of piperacillin and related beta-lactam antibiotics may remain impaired for prolonged periods.
机译:已评估了11例因肺门胆管癌引起的梗阻性黄疸患者的哌拉西林胆汁排泄情况。在初步经皮经肝胆管造影术前30分钟给予1克静脉注射剂量后,在7例患者的胆汁中未检测到药物。在另外四个中,药物浓度远远低于血清中的相应水平。经过长达28天的外部胆道引流后,静脉内给药后胆汁中的抗生素水平仅微增。结果表明,尽管通过血浆胆红素的下降来评估外部胆道减压可改善肝功能损害,但是胆汁中哌拉西林和相关β-内酰胺类抗生素的消除可能会长期受损。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号